Zynyz
Generic name: Retifanlimab-dlwr
Dosage form: injection
Drug class:
Anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Usage of Zynyz
Zynyz is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma in adults.
Zynyz is a programmed death receptor-1 (PD-1)–blocking antibody (also called an immune checkpoint inhibitor) that works by binding to the PD-1 protein on immune T-cells to prevent the interaction with PD-L1, a protein that is often found on some cancer cells.
When the PD-1 protein on an immune cell interacts with the PD-L1 protein on a cancer cell, the cancer cell is considered healthy and is left alone. By blocking the interaction with PD-1, Zynyz works to remove the "brakes" on the immune system, allowing it to attack cancer cells more effectively.
Zynyz side effects
Zynyz can cause serious side effects. See Important information.
The most common side effects include:
These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Zynyz
Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:
Pregnancy
Tell your healthcare provider if you are pregnant or plan to become pregnant. Zynyz can harm your unborn baby. Females who are able to become pregnant:
Breastfeeding
Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if Zynyz passes into your breast milk.
Do not breastfeed during treatment, and for 4 months after your last dose.
Relate drugs
- Atezolizumab
- Avelumab
- Bavencio
- Cemiplimab
- Cemiplimab-rwlc
- Dostarlimab
- Dostarlimab-gxly
- Durvalumab
- Imfinzi
- Jemperli
- Keytruda
- Libtayo
- Nivolumab
- Opdivo
- Pembrolizumab
- Retifanlimab
- Retifanlimab-dlwr
- Tecentriq
- Zynyz
How to use Zynyz
Usual Adult Dose for Merkel Cell Carcinoma
500 mg as an intravenous infusion over 30 minutes every 4 weeks until disease progression, unacceptable toxicity, or up to 24 months.
Use: For the treatment of adult patients with metastatic or recurrent locally advanced Merkel cell carcinoma.
Warnings
Zynyz is a medicine that may treat Merkel cell carcinoma by working with your immune system. It can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these problems at the same time. These problems may happen anytime during treatment or even after your treatment has ended.
Call or see your healthcare provider right away if you develop any new or worsening signs or symptoms, including: Lung problems.
Intestinal problems.
Liver problems.
Hormone gland problems.
Kidney problems.
Skin problems.
Problems can also happen in other organs and tissues. These are not all of the signs and symptoms of immune system problems that can happen during treatment with this medicine. Call or see your healthcare provider right away for any new or worsening signs or symptoms, which may include:
Infusion reactions that can sometimes be severe. Signs and symptoms of infusion reactions may include:
Rejection of a transplanted organ. Your healthcare provider should tell you what signs and symptoms you should report and monitor you, depending on the type of organ transplant that you have had.
Complications, including graft-versus-host disease, in people who have received a bone marrow (stem cell) transplant that uses donor stem cells (allogeneic). These complications can be serious and can lead to death. These complications may happen if you underwent transplantation either before or after being treated with Zynyz. Your healthcare provider will monitor you for these complications.
Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider will check you for these problems during your treatment. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may also need to delay or completely stop treatment if you have severe side effects.
What other drugs will affect Zynyz
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions